Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. Issue 1 (2nd January 2019)

• Record Type: Journal Article
• Authors: Stahl, Maximilian; DeVeaux, Michelle; Montesinos, Pau; Itzykson, Raphaël; Ritchie, Ellen K.; Sekeres, Mikkael A.; Barnard, John; Podoltsev, Nikolai A.; Brunner, Andrew; Komrokji, Rami S.; Bhatt, Vijaya R.; Al-Kali, Aref; Cluzeau, Thomas; Santini, Valeria; Roboz, Gail J.; Fenaux, Pierre; Litzow, Mark; Fathi, Amir T.; Perreault, Sarah; Kim, Tae Kon; Prebet, Thomas; Vey, Norbert; Verma, Vivek; Germing, Ulrich; Bergua, Juan; Serrano, Josefina; Gore, Steven D.; Zeidan, Amer M.
• Is Part Of: Leukemia & lymphoma. Volume 60:Issue 1(2019)
• Page Start: 246
• Page End: 249
• Publication Date: 2019-01-02
• Subjects: Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.1080/10428194.2018.1468893
• Languages: English
• ISSNs: 1042-8194